News

Crime-comedy icon, Guy Ritchie, will soon be back at the box office with a heist adventure film, Fountain of Youth.
Semaglutide and tirzepatide were the least cost-effective of four obesity drugs examined in a microsimulation model. A multifaceted approach is needed to reduce financial barriers to obesity ...
Apple TV+ has debuted the first official trailer for Guy Ritchie's Fountain of Youth, an upcoming heist adventure film that promises to unlock one of the world's greatest mysteries. The film ...
April 1 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Tuesday it had sued two mass compounders for selling unapproved products that contain tirzepatide, the main ingredient in its popular ...
INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list. Hundreds of ...
Opens in a new tab or window Last week marked the FDA's deadline for compounders to stop making the obesity drug tirzepatide (Zepbound), leaving some patients unsure where to turn next.